scholarly journals Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry

Haematologica ◽  
2019 ◽  
Vol 105 (3) ◽  
pp. 640-651 ◽  
Author(s):  
Marlijn Hoeks ◽  
Ge Yu ◽  
Saskia Langemeijer ◽  
Simon Crouch ◽  
Louise de Swart ◽  
...  
Keyword(s):  
Myelodysplastic Syndromes ◽  
Lower Risk ◽  
Chelation Therapy ◽  
Iron Chelation ◽  
Iron Chelation Therapy

Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes

2014 ◽  
Vol 38 (5) ◽  
pp. 557-563 ◽  
Author(s):  
Michel Delforge ◽  
Dominik Selleslag ◽  
Yves Beguin ◽  
Agnès Triffet ◽  
Philippe Mineur ◽  
...  
Keyword(s):  
Myelodysplastic Syndromes ◽  
Lower Risk ◽  
Chelation Therapy ◽  
Iron Chelation ◽  
Iron Chelation Therapy

The Role of Iron Chelation Therapy for Patients With Myelodysplastic Syndromes

2011 ◽  
Vol 9 (1) ◽  
pp. 65-75 ◽  
Author(s):  
David P. Steensma
Keyword(s):  
Iron Overload ◽  
Myelodysplastic Syndromes ◽  
Chelation Therapy ◽  
Iron Chelation ◽  
Clinical Intervention ◽  
Iron Chelation Therapy ◽  
Careful Attention ◽  
High Quality ◽  
Iron Parameters

The appropriate role of iron chelation therapy in the management of patients with myelodysplastic syndromes (MDS) is currently controversial. Some investigators interpret data to indicate that careful attention to iron parameters, with early initiation of iron chelation in patients with evidence suggesting transfusion-associated iron overload, is an important component of high-quality MDS patient care. Other physicians are more skeptical, noting that chelation can be cumbersome or costly, has associated risks, and has not yet been shown to reduce morbidity or mortality in the MDS setting. This article reviews the extent to which iron chelation therapy might be either an important clinical intervention in MDS or a distraction from more pressing clinical concerns.

Iron Chelation Therapy is Associated with Improved Survival in Lower Risk MDS

2017 ◽  
Vol 55 ◽  
pp. S164
Author(s):  
D. Singhal ◽  
R. Chhetri ◽  
L.A. Wee ◽  
M. Kutyna ◽  
S. Nath ◽  
...  
Keyword(s):  
Lower Risk ◽  
Chelation Therapy ◽  
Iron Chelation ◽  
Iron Chelation Therapy
Sign in / Sign up

Export Citation Format

Share Document